Can roflumilast, a phosphodiesterase-4 inhibitor, improve clinical outcomes in patients with moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis

被引：0
|
作者：
Jian Luo
Ke Wang
Dan Liu
Bin-Miao Liang
Chun-Tao Liu
机构：
[1] Sichuan University,Department of Respiratory and Critical Care Medicine
[2] Sichuan University,Department of Critical Care Medicine, West China School of Medicine and West China Hospital
来源：
Respiratory Research | / 17卷
关键词：
Roflumilast; Chronic obstructive pulmonary disease; Lung function; Exacerbation; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Can roflumilast, a phosphodiesterase-4 inhibitor, improve clinical outcomes in patients with moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis
    Luo, Jian
    Wang, Ke
    Liu, Dan
    Liang, Bin-Miao
    Liu, Chun-Tao
    RESPIRATORY RESEARCH, 2016, 17
  • [2] Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis
    Luo, Jian
    Wang, Ke
    Liu, Dan
    Liang, Bin-Miao
    Liu, Chun-Tao
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [3] Roflumilast: A Phosphodiesterase-4 Inhibitor for the Treatment of Severe Chronic Obstructive Pulmonary Disease
    Pinner, Nathan A.
    Hamilton, Leslie A.
    Hughes, Anthony
    CLINICAL THERAPEUTICS, 2012, 34 (01) : 56 - 66
  • [4] The role of the phosphodiesterase-4 inhibitor, roflumilast, in chronic obstructive pulmonary disease
    Wedzicha, Jadwiga A.
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2010, 120 (1-2): : 9 - 10
  • [5] Clinical Efficacy of a Selective Phosphodiesterase-4 Inhibitor (Roflumilast) in Patients with Chronic Obstructive Pulmonary Disease and Metabolic Syndrome
    Ignatova, G.
    Blinova, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [6] Roflumilast: A new phosphodiesterase 4 inhibitor for chronic obstructive pulmonary disease
    Baker, Erica L.
    Baker, William L.
    FORMULARY, 2010, 45 (01) : 6 - 13
  • [7] Does roflumilast improve dyspnea in patients with chronic obstructive pulmonary disease? A meta-analysis
    Pan, Lei
    Guo, Yong-Zhong
    Zhang, Bo
    Yan, Jun-Hong
    JOURNAL OF THORACIC DISEASE, 2013, 5 (04) : 422 - 429
  • [8] Efficiency and safety of roflumilast combined with long-acting bronchodilators on moderate-to-severe stable chronic obstructive pulmonary disease patients: a meta-analysis
    Luo, Peng
    Li, Shuo
    Chen, Yitai
    Luo, Yuwen
    Li, Yun
    Wang, Kai
    Huang, Yuxia
    Chen, Xin
    JOURNAL OF THORACIC DISEASE, 2016, 8 (09) : 2638 - +
  • [9] Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease
    Rabe, Klaus F.
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (01) : 53 - 67
  • [10] Treatment of Chronic Obstructive Pulmonary Disease with Roflumilast, a New Phosphodiesterase 4 Inhibitor
    Gross, Nicholas J.
    Giembycz, Mark A.
    Rennard, Stephen I.
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2010, 7 (02) : 141 - 153
12345